We treated GC cells with the glycolysis inhibitor galloflavin (50 μM) and observed that it suppressed the increase in proliferation caused by TRIM50 knockdown, whereas the knockdown of TRIM50 did not induce any changes in cell proliferation under the precondition of glycolysis inhibition (Figure 4G-I), indicating that TRIM50 inhibits cell proliferation through the suppression of glycolysis. The gene discussed is TRIM50; the disease is gastric cancer.